NEWS

The Biologics Manufacturing Centre (BMC) will participate in the Bloom Burton & Co. Healthcare Investor Conference, taking place on May 5–6, 2025, at the Metro Toronto Convention Centre.

This premier event brings together Canadian, U.S., and international investors with innovative companies across the health sector—from early-stage startups to publicly traded corporations. It is a key gathering for stakeholders driving the future of life sciences in Canada.

BMC will be represented by Patrick Daoust, Business Development Manager, who will take part in strategic meetings to highlight BMC’s expertise in biomanufacturing and explore new opportunities for collaboration.

Learn more about the event: Bloom Burton & Co. Healthcare Investor Conference